LN LECs can also cross-present tumor antigens to promote CD4 suppression and produce immunosuppressive molecules such as nitric oxide, TGF-β, and IDO to promote an immunosuppressive nodal microenvironment [137–142]. The gene discussed is TGFB1; the disease is neoplasm.